Nama's AI scorecard currently rates Omada Health Hold (5.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is OMDA's P/E ratio?

Omada Health trades at a trailing price-to-earnings ratio of 43.1.

When does OMDA report earnings?

Omada Health's next scheduled report is on Mar 4, 2027. Analysts expect EPS of $0.11.

What is the OMDA price target?

The median analyst price target from 12 analysts is $28.00, with a range of $22.00 – $35.00.

Is OMDA Shariah compliant?

Nama's AAOIFI-style screen reads Omada Health as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Nama Insights

Omada Health (OMDA)

Healthcare · Health Information Services · NASDAQ

Omada Health (OMDA) is a Healthcare company in the Health Information Services industry. It has a market capitalization of $1.16B, a trailing price-to-earnings ratio of 43.1 and a free-cash-flow yield of 1.8%. Over the most recent reported fiscal year, revenue grew 53.2%. Nama's AI scorecard rates it Hold, 5.5 out of 10. On 12-month momentum it ranks in the lagging band of its market.

AI scorecard

Hold · 5.5/10

The sections balance. As of Nov 7, 2026.

Momentum

Lagging · -4.5% over 12 months ex. last

Second-worst fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-46.9%

How far the last close sits under the highest price of the past five years.

Market cap	$1.16B
Trailing P/E	43.1
Price / book	4.5
Price / sales	3.8
FCF yield	1.8%
Dividend yield	—
Gross margin	68.2%
Operating margin	-0.1%
Net margin	1.4%
Revenue growth (YoY)	+53.2%
Revenue growth (3-yr annual)	+42.9%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Beta	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Health Information Services

OMDA earnings

Next report: Mar 4, 2027 (Q4 2026, EPS estimate $0.11). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 5, 2026	$0.21	$0.10	+110.0%	—
Q2 2026	Aug 6, 2026	$0.20	$0.06	+233.3%	$87.83M
Q1 2026	May 7, 2026	$0.05	-$0.04	+225.0%	$78.05M
Q4 2025	Mar 5, 2026	$0.16	$0.03	+433.3%	$75.85M

OMDA analyst price target

Median target $28.00 from 12 analysts, ranging $22.00 – $35.00.

Health Information Services peers

Ticker	Company	Market cap	P/E
VEEV	Veeva Systems	$49.18B	35.0
TEM	Tempus AI	$13.87B	—
BTSG	BrightSpring Health Services	$13.36B	39.3
HNGE	Hinge Health	$9.34B	51.7
HQY	HealthEquity	$8.57B	23.3
TXG	10x Genomics	$7.72B	296.4
DOCS	Doximity	$5.79B	23.7
WAY	Waystar	$5.45B	17.2

Explore live OMDA data on Nama Insights →

OMDA FAQ

Is OMDA a buy?: Nama's AI scorecard currently rates Omada Health Hold (5.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is OMDA's P/E ratio?: Omada Health trades at a trailing price-to-earnings ratio of 43.1.
When does OMDA report earnings?: Omada Health's next scheduled report is on Mar 4, 2027. Analysts expect EPS of $0.11.
What is the OMDA price target?: The median analyst price target from 12 analysts is $28.00, with a range of $22.00 – $35.00.
Is OMDA Shariah compliant?: Nama's AAOIFI-style screen reads Omada Health as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.